Join us in person or online to learn more about Evrysdi.
Genentech is pleased to offer in-person and online educational events. These events give you the opportunity to learn about Evrysdi from experts and hear directly from people currently taking Evrysdi. To find and register for an in-person event in your area, please enter your ZIP code or choose your local PAL representative name below. To register for online events, follow the "Register" links from the list below.
Please enter your ZIP code or local PAL
(Search results will show In-Person Events within a 100-mile radius and all Virtual Events by date.)
Tuesday, April 9, 6:00 PM CDT
Manisha Korb, MD
University of California, Irvine
Nebraska, Iowa, South Dakota, Kansas, Missouri and Montana
Thursday, April 11, 6:30 PM EDT
Omer Hamid, MD, MD-S
Nemours Children's Hospital
Tony Isabella, RRT
This event is currently not open for registration. Please search for another event.
Before taking Evrysdi, tell your healthcare provider about all of your medical conditions, including if you:
are pregnant or plan to become pregnant, as Evrysdi may harm your unborn baby. Ask your healthcare provider for advice before taking this medicine
are a woman who can become pregnant:
Before you start your treatment with Evrysdi, your healthcare provider may test you for pregnancy
Talk to your healthcare provider about birth control methods that may be right for you. Use birth control while on treatment and for at least 1 month after stopping Evrysdi
Pregnancy Registry. There is a pregnancy registry for women who take Evrysdi during pregnancy. The purpose of this registry is to collect information about the health of the pregnant woman and her baby. If you are pregnant or become pregnant while receiving Evrysdi, tell your healthcare provider right away. Talk to your healthcare provider about registering with the Evrysdi Pregnancy Registry. Your healthcare provider can enroll you in this registry or you can enroll by calling 1-833-760-1098 or visiting www.evrysdipregnancyregistry.com
are an adult male. Evrysdi may affect a man’s ability to have children (fertility). Ask a healthcare provider for advice before taking this medicine
are breastfeeding or plan to breastfeed. It is not known if Evrysdi passes into breast milk and may harm your baby
Tell your healthcare provider about all the medicines you take
You should receive Evrysdi from the pharmacy as a liquid. If the medicine in the bottle is a powder, do not use it. Contact your pharmacist for a replacement
Avoid getting Evrysdi on your skin or in your eyes. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water
The most common side effects of Evrysdi include:
For later-onset SMA:
For infantile-onset SMA:
runny nose, sneezing, sore throat, and cough (upper respiratory infection)
lung infection (lower respiratory infection)
These are not all of the possible side effects of Evrysdi. For more information on the risk and benefits profile of Evrysdi, ask your healthcare provider or pharmacist.
You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555.